High affinity alpha7 nAChR partial agonist (Ki = 1.1 nM in rat; Emax < 10% of the response to ACh in rat and human). Inhibits ACh (IC50 = 2.7 nM) at alpha7 nAChR. Reduces LPS-induced TNF-alpha release from microglia enriched cultures. Anti-inflammatory.